Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
South Korea · Delayed Price · Currency is KRW 5,110.00
-30.00 (-0.58%)
Jun 30, 2026, 3:30 PM KST
Vaxcell-Bio Therapeutics Market Cap
Vaxcell-Bio Therapeutics has a market cap or net worth of 118.85 billion as of June 30, 2026. Its market cap has decreased by -47.80% in one year.
Market Cap
118.85B
Enterprise Value
80.80B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5,110.00
Market Cap Chart
Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has decreased from 160.24B to 118.85B, a decrease of -25.83%. That is a compound annual growth rate of -5.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 118.85B | -48.85% |
| Dec 30, 2025 | 232.34B | -3.12% |
| Dec 30, 2024 | 239.82B | -53.54% |
| Dec 28, 2023 | 516.20B | -0.71% |
| Dec 29, 2022 | 519.87B | -21.31% |
| Dec 30, 2021 | 660.68B | -73.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioneer | 160.54B |
| JETEMA, | 158.66B |
| Macrogen | 126.74B |
| NeoImmuneTech | 124.57B |
| Genexine | 104.60B |
| Amicogen | 103.28B |
| MedPacto | 96.31B |
| CG Invites | 78.28B |